Your browser doesn't support javascript.
loading
Potential small-molecule drugs as available weapons to fight novel coronavirus (2019-nCoV): A review.
Rahimkhoei, Vahid; Jabbari, Nassrollah; Nourani, Aynaz; Sharifi, Sina; Akbari, Ali.
Afiliación
  • Rahimkhoei V; Solid Tumor Research Center, Research Institute for Cellular and Molecular Medicine, Urmia University of Medical Sciences, Urmia, Iran.
  • Jabbari N; Solid Tumor Research Center, Research Institute for Cellular and Molecular Medicine, Urmia University of Medical Sciences, Urmia, Iran.
  • Nourani A; Department of Health Information Technology, School of Allied Medical Sciences, Urmia University of Medical Sciences, Urmia, Iran.
  • Sharifi S; Disruptive Technology Laboratory, Massachusetts Eye and Ear and Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA.
  • Akbari A; Solid Tumor Research Center, Research Institute for Cellular and Molecular Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Cell Biochem Funct ; 39(1): 4-9, 2021 Jan.
Article en En | MEDLINE | ID: mdl-32803762
ABSTRACT
Since the new coronavirus known as 2019-nCoV (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) has widely spread in Wuhan, China, with severe pneumonia, scientists and physicians have made remarkable efforts to use various options such as monoclonal antibodies, peptides, vaccines, small-molecule drugs and interferon therapies to control, prevent or treatment infections of 2019-nCoV. However, no vaccine or drug has yet been confirmed to completely treat 2019-nCoV. In this review, we focus on the use of potential available small-molecule drug candidates for treating infections caused by 2019-nCoV.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Cell Biochem Funct Año: 2021 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Cell Biochem Funct Año: 2021 Tipo del documento: Article País de afiliación: Irán